NovaVision, Inc.
Improving the vision of patients with neurological visual impairments and enhancing their quality of life.
Improving the vision of patients with neurological visual impairments and enhancing their quality of life.
NovaVision, Inc. is a health care startup focused on improving the vision of patients with neurological visual impairments. The company offers Vision Restoration Therapy (VRT), a home-based therapy designed to restore lost vision resulting from Stroke or Traumatic Brain Injury, which is the only FDA Cleared therapy targeted at this type of vision loss. Their NeuroEyeCoach is a compensation technique that helps patients direct their gaze towards affected areas, bringing previously undetected objects into sight. This can be completed at home on the patient's own computer in 2-4 weeks. With a significant scientific background, the company has a distinguished Scientific Advisory Board comprising renowned professors and physicians such as Arash Sahraie, Alvaro Pascual-Leone, Joseph Zihl, Jose Romano, and Jason S. Barton. Founded in 1998, NovaVision, Inc. has the potential to revolutionize the field of vision solutions for patients with neurological visual impairments, presenting an attractive opportunity for venture capital investment in the health care industry.
There is no investment information
We care about your data, and we'd love to use cookies make your experience better.